Transgenic Group Inc. (TYO:2342)
Japan · Delayed Price · Currency is JPY 272.00
+12.00 (4.62%)
At close: Mar 27, 2026
Transgenic Group Market Cap
Transgenic Group has a market cap or net worth of 4.53 billion as of March 27, 2026. Its market cap has increased by 51.11% in one year.
Market Cap
4.53B
Enterprise Value
5.23B
Revenue
12.89B
Ranking
n/a
PE Ratio
n/a
Stock Price
272.00
Market Cap Chart
Since July 2, 2003, Transgenic Group's market cap has decreased from 9.78B to 4.53B, a decrease of -53.67%. That is a compound annual growth rate of -3.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 4.53B | -10.82% |
| Dec 30, 2025 | 5.08B | 73.30% |
| Dec 30, 2024 | 2.93B | -33.27% |
| Dec 29, 2023 | 4.39B | -20.08% |
| Dec 30, 2022 | 5.50B | -27.38% |
| Dec 30, 2021 | 7.57B | -5.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chiome Bioscience | 7.22B |
| PRISM BioLab Co.,LTD | 7.20B |
| TMS Co., Ltd. | 6.60B |
| Soiken Holdings | 6.41B |
| Noile-Immune Biotech | 6.41B |
| Linical | 6.19B |
| Kohjin Bio | 6.09B |
| Ribomic | 5.32B |